Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
More smoke. Let's assume you use no leverage. Now, how much money have you made with TA? Show us your buy and sells over, say, the past 2 years.
Today might be the day. The crowd is hushed, the tension unbearable...
We seem to be transitioning from "never staying below 0.40 for long" to "never staying above 0.40 for long".
Except that you never say, "buy now", or "sell now" so it's impossible to determine what your "profits" are. You keep blowing smoke.
Oops.. now it's two pennies.
One penny to go.
Which is precisely what we can say about the fewer than half the times that you correctly predicted the stock price direction with technical analysis.
My gut. I was right. At least as much as any chart readers are.
Prediction: The stock will close higher tomorrow.
Yup. I remember when Rawnoc was saying that 2 clams was coming. How many of us wish we had sold above 2 clams!
We're 2.5 cents away from declaring the strangle contest winner. The tension mounts.
In other words, no news. NNVC has been "planning IND-enabling safety/toxicology studies" for Shinglescide for a couple of yesrs now.
I have no idea who or what ConWar is. Pump Terminator was a guy who wrote an article on Seeking Alpha making the case for shorting NNVC. He said there was 80% downside when the price was over $4. As we see, he was conservative -- so far we have over 90% downside. Of course PT is hated by all the bulls, they blame him for the stock going down, when in reality NNVC has accomplished nothing of value since the article was written, and that is why the stock went down.
The close is 0.40 even. Is the rally over?
Less than $9000 worth of shares traded today.
With this volume, if Rentec decides to unload its position it would take 24 days to sell it all (assuming nobody else was selling).
Today the gain was over 10%. How many stocks do you know of that gain 10% in a day? NNVC rocks!
Some poor guy on the bull's board is losing it:
Massive rally! NNVC finally closes above 0.40! Of course, we know that some patient shareholder is just waiting for the price to rise a few pennies more so he can dump another big block of shares. NNVC share holders are now engaged in a game of chicken.
The fourth day in a row with a close below 0.40. Traders are beginning to learn -- buyers at 0.41 are suckers.
Rally. Up a penny. But, still, for the third day in a row, the price has closed below 0.40.
Something on the bull's board we can all agree with:
In any case, the short cabal has had nothing to worry about, new CEO or no CEO. It's funny how some people still blame the short cabal for NNVC's stock price, when the total short position is trivially small.
Third day in a row with a closing price below 0.40. And again, 3 cents away from announcing the strangle contest winner.
It's the second day in a row with the close below 0.40. Although just below.
There's nothing there we don't already know.
It's very weird realizing that there are still buyers out there. At the very least, even if they believe the nanoviricide technology works and will eventually be proven in humans, they must know that a strongly dilutive financing event is in the near future if NNVC is to survive at all.
Back above 0.40. Rally!
Yikes. Well, I'm not surprised. NNVC was not going to be able to bring in a top tier CEO.
$14,000 worth of shares traded today. Woo hoo.
So far very low volume. Call up you broker and make an appointment if you want to trade your shares.
On a positive note -- we have yet to see NNVC close below 0.40 two days in a row.
It's sort of weird reading the bull's board and see people talking as if they still expect NNVC to get something done before it runs out of money.
I intended that question for the general audience. Boniuk is an insider and a major stockholder, so presumably he has to file an SEC Form 4 for any stock sales. I haven't been able to find any such filings.
One thing is clear -- the market has not decided that the new CEO will save the company.
The key question is -- has Milton Boniuk been selling off his huge share position? Or does he not believe that a huge loss is better than an even bigger loss?
Yes we've seen that. It's weird. It's as though they imagined that NNVC might continue beyond 2019.
It wouldn't matter if Dr. T's previous job had led to a blockbuster multi billion dollar approved drug. NNVC is running out of money. The very first thing a CEO has to do is raise more money. And lots of it, so NNVC can be doing clinical trials before asking for more. (And remember NNVC will probably take years to get that far.) At a minimum, NNVC should raise $20 million. At the current price that would require selling 50 million new shares. That's a 75% increase in share count. The dilution alone would send the price down to about 0.23, but allowing for the fact that there would be more optimism about the company surviving maybe the price would be 0.30. But wait -- nobody's going to buy 50 million shares at 0.40 that immediately lose 25% of their value. So the new shares must be offered at a significant discount, say 0.25. Now 80 million shares have to be offered to raise $20 million. The share count increases by 123%. Now the dilution drops the priced down to 0.18, which maybe recovers a nickel due to optimism up to 0.23. Oh, oh, Mr. Big is underwater again. See how this works? It's really going to suck raising money for this dog and existing shareholders are going to get reamed.
Remember that top tier CEO candidates all have better options than joining a company that will run out of money in less than a year. So NNVC had to settle for a second or third tier CEO.
Fun fact: Zincfinger bailed out of most of his NNVC position at 10 times the current price.
Frankly I see nothing damning in any of the quoted remarks. The first statement was just an honest assessment based on in vitro and animal studies, the second statement was the bitter result of actual human studies. In actual drug development it is not at all uncommon for there to be a sharp disparity in these two cases.